Andere Sprachen SciSparc Ltd.

Aktien

A1CY7H

IL0010951403

SPRC

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.05.2024			% 5 Tage	% 1. Jan.
1,22 ^USD	+1,67 %		-2,40 %	-75,00 %

01.04.	SciSparc Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
18.03.	SciSparc Ltd. erhält ein weiteres Patent und stärkt damit seine Kerntechnologie in Kanada	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

SciSparc to Acquire AutoMax	11.04.
SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd.	11.04.
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research	21.03.
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	18.03.
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	18.03.
SciSparc Ltd. Receives Another Patent, Strengthening its Core Technology in Canada	18.03.
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial	14.03.
SciSparc Ltd. Announces Successfully Dosed the First Patient in Its SCI-210 Clinical Trial At the Soroka Medical Center for Pediatric Patients	14.03.
SciSparc : MitoCareX Update - Form 6-K	13.03.
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	12.03.
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	12.03.
Top Premarket Gainers	08.03.
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	08.03.
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	08.03.
SciSparc Ltd. Announces Enrollment of First Patient for Its Clinical Trial for Children with Autism Spectrum Disorder	08.03.
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07.03.
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07.03.
Scisparc Ltd. Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07.03.
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology	06.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen SciSparc Ltd.

Aktien

A1CY7H

IL0010951403

SPRC

Andere Sprachen

Filter